Logo

licensing agreement

Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M

IDT has acquired the VariantPlex, FusionPlex, LiquidPlex, and Immunoverse panels, powered by Invitae's anchored multiplex PCR (AMP) technology.

EnPlusOne Biosciences Nabs Exclusive License to RNA Synthesis Technology from Wyss Institute

EnPlusOne Bio has secured a worldwide license to the ezRNA platform developed in the lab of George Church, one of the firm's cofounders.

ERS Genomics Licenses CRISPR-Cas9 Patents to Crown Bioscience

ERS was founded to provide access to CRISPR-Cas9 patents held by Emmanuelle Charpentier, who shares the IP with Jennifer Doudna, UC, and the University of Vienna.

ERS Genomics Licenses CRISPR-Cas9 IP to Cosmo Bio

ERS was founded to provide access to CRISPR-Cas9 patents stemming from research conducted at the University of California and the University of Vienna.

UPDATE: Sherlock Biosciences, Tolo Biotech Reach Another CRISPR Licensing Agreement for Dx

The deal builds on an earlier agreement between the firms covering Sherlock's Cas12 and Cas13 CRISPR diagnostic methods.

Oct 24, 2022

TruDiagnostic, North Carolina State University Ink Licensing Deal for Methylation Microarray

Oct 18, 2022

BioSkryb Genomics Licenses Amplification Tech to CooperSurgical

Oct 17, 2022

Sherlock Biosciences Licenses Ambient Temperature Amplification Tech From Wyss Institute

Oct 12, 2022

NanoMosaic Licenses Post-Operative Delirium Test From Mass General, Harvard Medical School

Oct 7, 2022

Bioinfra, 20/20 GeneSystems Ink Deal for US Sales of Multi-Cancer Test

Sep 8, 2022

Sigma-Aldrich, GenOway Modify CRISPR Strategic Alliance

Aug 23, 2022

Harvard University, Wyss Institute License Protein Detection Technology to Spear Bio

Aug 4, 2022

Innova Medical Group Licenses Molecular Testing Tech From University of Birmingham

Aug 3, 2022

Codexis, Molecular Assemblies Ink Commercial License and Enzyme Supply Agreement

Aug 2, 2022

Caris, Xencor Ink Antibody Target Discovery Collaboration, License Agreement

Aug 1, 2022

Active Motif, EpiCypher End Patent Litigation With Targeted Transposition Tech Deal

Jul 28, 2022

Bio-Techne Licenses Protein Degradation Technology From University of Dundee

Jul 26, 2022

ERS Genomics Licenses CRISPR/Cas9 IP to Lepton Pharmaceuticals

Jul 18, 2022

GenDx Licenses cfDNA Assay for Rejection Monitoring From Medical College of Wisconsin

Jul 6, 2022

Guardant Health Licenses Genomic Cancer Assays to Adicon for Testing in China

Jun 2, 2022

GenDx Licenses Proximity Ligation Assay From Dovetail Genomics for Use in Transplant Diagnostics

May 16, 2022

Aldevron Gets License From Inscripta to Manufacture, Sell CRISPR Nuclease

May 13, 2022

SomaLogic Plans New Data Products, Licensing and Test Development Agreements
Premium

Apr 28, 2022

Illumina Licenses Allelica Polygenic Risk Score Software

Apr 26, 2022

ERS Genomics Licenses CRISPR-Cas9 IP to Sumitomo Pharma

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.